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Background: African trypanosomiasis is a major disease of economic and public health importance affecting
agricultural and human development. The search for alternative compounds against African trypanosomiasis is
justified by various limitations of existing chemotherapeutic agents. This study was aimed at screening the
hydromethanolic and dichloromethane (DCM) crude extracts of aerial parts of Artemisia abyssinica for in vivo
antitrypanosomal activity against Trypanosoma congolense isolate in mice.
Methods: The aerial parts of the plant were extracted by maceration technique using dichloromethane and 80%
methanol to obtain the corresponding crude extracts. The plant extracts at doses of 100, 200 and 400 mg/kg body
weight were administered intraperitoneally daily for 7 days to mice infected with Trypanosoma congolense.
Diminazene aceturate and distilled water were used as positive and as negative controls respectively. The level of
parasitaemia, body weight, packed cell volume, differential leukocyte counts and mean survival period were
monitored.
Results: The study showed that the DCM extract at 200 and 400 mg/kg, and the hydromethanolic extract at
400 mg/kg reduced parasitaemia (p < 0.05), ameliorated anaemia (p < 0.05), prevented body weight loss (p < 0.05)
and resulted in significant increase in neutrophil levels (p < 0.05) and marked decrease in lymphocyte levels
(p < 0.05) compared to the negative control.
Conclusions: This study established that aerial parts of A. abyssinica have antitrypanosomal potential and can be
considered a potential source of new drugs for the treatment of tropical diseases caused by trypanosomes.
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African trypanosomiasis, a parasitic infection caused by
single-celled protozoan parasites of the genus Trypano-
soma that are primarily transmitted by the bite of infected
tsetse flies. Human trypanosomiasis is caused by two sub-
species of Trypanosoma brucei: T. brucei gambiense, and
T. brucei rhodesiense while African animal trypano-
somiasis is a group of diseases of ruminants, camels,
equines, swine and carnivores caused by different tryp-
anosome species [1-3]. Both, human and animal trypano-
somiases negatively affect the whole economy of Africa by* Correspondence: workineh.shibeshi@aau.edu.et
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unless otherwise stated.weakening both human and animals health [4].The
unavailability of vaccine against trypanosomiasis and
escalating costs of initiating and maintaining tsetse
control campaigns have led to the vast tsetse infested
areas of Africa being almost completely reliant on the
use of trypanocidal drugs [5]. However, only a small group
of chemoprophylactic and chemotherapeutic trypanocidal
compounds are currently in use to which resistance has
developed [6]. Furthermore, the registered trypanocides
are beset with several additional drawbacks such as fre-
quent toxicity, lengthy parenteral administration, lack of
efficacy and unaffordable price [7]. The need for alterna-
tive new molecules that are safe, effective and affordable is
urgent. It has been observed that natural products derived
from plants offer novel possibilities to obtain new drugsLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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antitrypanosomal activity of traditionally used plants has
been a major area of contemporary research focus [8]. In
recent years, very small Ethiopian potential medicinal
plants have been studied for their antitrypanosomal activ-
ity [9,10]. There is a need for the development of new
agents to complement the existing drugs for the treatment
of African trypanosomiasis. Artemisia abyssinica, known
by various common names in Ethiopia, is used as a trad-
itional remedy for several infectious and noninfectious dis-
eases including typanosomiasis [11-13]. Nibret and Wink
[9] reported the in vitro antitrypanosomal activity and
cytotoxicity of the plant against drug sensitive T. brucei.
Our former report [14] shows significant in vitro anti-
trypanosomal activity of crude extracts of aerial parts of
the plant against T. congolense. Therefore, this study was
aimed to evaluate the in vivo antitrypanosomal activity
of crude extracts of aerial parts of the plant against field
isolate of T. congolense in mice models of infection.
Methods
Chemicals
The chemicals and reagents used for the experiment in-
clude absolute methanol (Cheshire, UK), dichloromethane
(ReAgent Chemical Services Ltd, UK), Tween-80 (BDH La-
boratory supplies Ltd, England), phosphate buffered saline
(PBS), 10% Giemsa stain (Shenyang Xin Guang, China),
diminazene aceturate (Techno Pharmchem, India).
Plant material
Fresh aerial parts of A. abyssinica were collected in
November 2011 from Sebeta, Oromia Regional State,
about 24 km South of Addis Ababa, Ethiopia. The fresh
plant material was wrapped with plastic sheets during
transportation. The plant specimen was identified by a tax-
onomist in the Department of Biology and voucher speci-
men (TF001) was deposited at the National Herbarium,
Addis Ababa University, Ethiopia.
Test organisms and experimental animals
The stocks of T. congolense that were originally isolated
from a pure natural infection of cattle in Arba Minch,
Ethiopia were obtained from the School of Veterinary
Medicine, Addis Ababa University. The organisms were
maintained by serial passages in mice until required as
used and described by different workers [15,16]. Swiss
albino mice (25–35 g) of both sexes aged 8–12 weeks,
obtained from the breeding colony of the Akililu Lemma
Institute of Pathobiology, Addis Ababa University, were
used for conducting experiments. Protocols for this ex-
periment were in accordance with the guidelines on care
and wellbeing of research animals [17] and were approved
by research and ethics committee of the School of
Pharmacy, Addis Ababa University.Preparation of plant extract
The collected plant material was shade dried at room
temperature and crushed into powder using laboratory
mortar and pestle. The powdered specimen was then ex-
tracted by maceration technique using dichloromethane
and 80% methanol to obtain the corresponding crude ex-
tracts. Briefly, 100 g of the powdered plant material was
weighed out and soaked separately in 1000 ml of solvents
for 72 hours. The mixture was first filtered using gauze
and then the filtrate was passed through sterile filter paper
(Whatman No. 3, Whatman Ltd. England). Then the fil-
tered extract was dried in an oven (hydromethanolic ex-
tract) at a temperature of 40°C and in rotary evaporator
(dichloromethane extract) at 38.5-42°C. The resulting ex-
tract was then weighed, recorded and kept in a refrigerator
until required for use.
Acute toxicity study
Acute toxicity study was done using the limit test dose
of 2000 mg/kg according to OECD guideline for testing
of chemicals using mice [18]. Six female Swiss albino
mice separately received orally 2000 mg/kg of the hydro-
methanolic and DCM extracts. The mice were observed
continuously for 1 h after administration of the extracts;
intermittently for 4 h, over a period of 24 h and for 14 days
for gross behavioral changes and other signs of toxicity
manifestations. The acute toxicity study indicated that
there were no visible signs of acute toxicity and death was
not observed at the limit dose tested (2000 mg/kg) during
the 14 days observation period.
Parasite inoculation and extract administration
The isolates were first inoculated heavily (104 trypanosomes/
mouse) to donor mice. After establishment of infection
(11–12 days post-inoculation), the donor mice were then
subjected to cardiac puncture and blood was collected
and immediately diluted with PBS for subsequent
in vivo test. A total of sixty healthy mice were randomly
grouped (n = 6) into ten groups (A-I, A-II, A-III, B-I, B-II,
B-III, C, D, E and F). All experimental groups of mice
(except group F) were then infected intraperitoneally
with 2000 trypanosomes/mouse in 0.2 ml of blood as
described and used by Ene et al. [19]. The animals were
left to develop parasitaemia, and when average parasit-
aemia became approximately 107.03 parasites/ml, groups
A-I, A-II and A-III were administered 100, 200 and
400 mg/kg of the hydromethanolic extract respectively.
Whereas groups B-I, B-II and B-III received respectively
100, 200 and 400 mg/kg of the DCM extract. Dose of
extracts were selected based on the results of acute tox-
icity. The extracts were administered to these groups
intraperitonneally every morning for seven days. The
extracts were dissolved and reconstituted in 2% Tween-
80 in distilled water. Group C and D received 3.5 and
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diminazene aceturate, respectively. Group E consisted
of the negative control which were infected with the
parasite and received the vehicle. The group F included
uninfected-untreated mice for reference.
Determination of parasitaemia and body weight change
The degree of parasitaemia was determined using the
method of Herbert and Lumsden [20]. Briefly, the method
involves microscopic counting of parasites per field in
blood smears from the peripheral blood obtained from tail
vein of of each mouse. Wet smears were prepared in tripli-
cates from each animal and the mean value of slide counts
was taken per sample examined microscopically. Loga-
rithm values of these counts were obtained by matching
with the table given by Herbert and Lumsden [20]. Parasit-
aemia was monitored every other day until the 14th day
and twice a week thereafter.
For the assessment of antitrypanosomal effect of the
extracts, the level of parasitaemia (expressed as log of
absolute number of parasites per ml of blood) in the
treated animals was compared to that of the control ani-
mals. The body weight of each mouse in all groups was
also measured on the day treatment commenced (day 0)
and every other day up to day 14 by a sensitive digital
weighing balance.
Determination of packed cell volume and differential
white blood cell count
The peripheral blood obtained from tail vein of of each
mouse was used for determination of packed cell volume
and differential white blood cell count. PCV was mea-
sured on days 0, 7 and 14 using Wintrobe’s method to
predict the effectiveness of the test extracts in preventing
haemolysis resulting from increasing parasitaemia associ-
ated with trypanosomiasis. The differential white blood
cell (WBC) counts were determined on Giemsa-stained
thin blood films obtained from each mouse on the 14th
day of extract administration.Table 1 Effect of dichloromethane crude extract of aerial part
of T. congolense infected mice
Treatment Dose
(mg/kg)
Parasitaemia level (log number)/ml
D0 D2 D4 D6
DCM ext 100 6.68 ± 0.23 7.08 ± 0.25 7.57 ± 0.26bc 7.83 ± 0.14
DCM ext 200 7.05 ± 0.18 7.04 ± 0.23 5.65 ± 1.18bc 3.80 ± 1.20
DCM ext 400 7.00 ± 0.30 6.95 ± 0.26 4.90 ± 0.98ac 2.80 ± 1.26
DA 3.5 7.09 ± 0.06 1.25 ± 1.25 1.90 ± 1.20a 3.30 ± 1.48
DA 28 7.13 ± 0.05 0.00 ± 0.00 0.00 ± 0.00a 0.00 ± 0.00
Distilled water 1 ml 6.94 ± 0.26 7.97 ± 0.12 8.67 ± 0.10 8.54 ± 0.07
Values are mean ± SEM; n = 6; D = day; D0 = the day treatment commenced; SEM = sta
aceturate; All superscripts indicate significance at p < 0.05 (a = compared to negat
d = compared to 400 mg/kg; e = compared to all groups, f = compared to all groupDetermination of mean survival time
Mortality was monitored daily and the number of days
from the time of inoculation of the parasite up to death
was recorded for each mouse in the treatment and control
groups throughout the follow up period for six weeks.
Statistical analysis
Values of the data obtained from the study were summa-
rized and expressed as mean ± standard error of mean.
Data analysis was performed using Statistical Packagefor
Social Science (SPSS), version 16.0. To compare the re-
sults obtained from different groups, one way ANOVA
followed by Tukey’s multiple comparison tests was per-
formed to determine statistical significance. P values less
than 0.05 were considered significant.
Results
Effect of crude extracts on parasitaemia
There were fluctuations in the level of parasitaemia of all
the treated groups which were, however, kept at relatively
low or very low level relative to infected-untreated control
especially at higher doses of both extracts. The best results
were obtained with DCM extract at an optimum dose of
400 mg/kg (Table 1) which was less effective compared
with 28 mg/kg of standard drug. Comparison with the
negative control revealed that the 400 mg/kg DCM extract
has kept parasitaemia at a significantly low level (p < 0.05
on days 4 through 14) and 200 mg/kg had considerably
reduced parasitaemia (p < 0.05) on days 6 and 8 of treat-
ment. The mice treated with 400 mg/kg hydromethano-
lic crude extract had significantly reduced parasitaemia
(p < 0.05 on days 6, 8 and 10 of treatment) when com-
pared with the infected-untreated group. Maximum
dose (28 mg/kg) of the standard (DA) was able to tem-
porarily clear the parasites from circulation within two
days of treatment although parasites reappeared from
day 12 of treatment until all animals relapsed on day
16.83 ± 1.28 (Tables 1 and 2). The 3.5 mg/kg DA was




D8 D10 D12 D14
bcd 6.31 ± 0.46cd 6.70 ± 1.37c 7.31 ± 0.44cd 6.41 ± 1.34c 34.33 ± 4.63
a 3.92 ± 1.37a 6.70 ± 0.30c 6.78 ± 0.39c 7.07 ± 0.32c 37.83 ± 3.49
a 1.95 ± 1.24a 3.70 ± 1.17a 4.85 ± 0.99abc 4.95 ± 1.01a 40.67 ± 2.42
a 4.60 ± 1.48c 6.12 ± 1.26c 7.41 ± 0.40cd 7.92 ± 0.27c 36.83 ± 4.36
a 0.00 ± 0.00ab 0.00 ± 0.00f 0.90 ± 0.90e 1.85 ± 1.17f 42.00 ± 0.00
8.46 ± 0.17 8.70 ± 0.06 8.14 ± 0.27 8.45 ± 0.21 34.33 ± 6.15
ndard error of mean; DCM=Dichloromethane; ext = extract; DA = Diminazene
ive control; b = compared to 3.5 mg/kg DA; c = compared to 28 mg/kg DA;
s but 400 mg/kg).
Table 2 Effect of hydromethanolic crude extract of aerial parts of A. abyssinica on parasitaemia and mean survival time
of T. congolense infected mice
Treatment Dose
(mg/kg)
Parasitaemia level (log number)/ml Mean
survival
time (days)
D0 D2 D4 D6 D8 D10 D12 D14
80% MeOH ext 100 7.16 ± 0.18 8.10 ± 0.17 7.80 ± 0.28bc 7.92 ± 0.26bcd 7.88 ± 0.16c 8.23 ± 0.21c 7.82 ± 0.16c 8.45 ± 0.13c 35.17 ± 6.49
80% MeOH ext 200 7.02 ± 0.09 7.90 ± 0.08 7.57 ± 0.24bc 6.90 ± 0.49c 6.70 ± 0.47c 7.95 ± 0.24c 7.69 ± 0.33c 8.10 ± 0.27c 36.50 ± 5.09
80% MeOH ext 400 7.17 ± 0.32 7.83 ± 0.28 6.05 ± 0.36bc 3.00 ± 1.36a 3.87 ± 1.37a 4.90 ± 1.00ac 7.30 ± 0.12c 7.15 ± 0.31c 38.17 ± 4.88
DA 3.5 7.09 ± 0.06 1.25 ± 1.25 1.90 ± 1.20ad 3.30 ± 1.48a 4.60 ± 1.48c 6.12 ± 1.26c 7.41 ± 0.40c 7.92 ± 0.27c 36.83 ± 4.36
DA 28 7.13 ± 0.05 0.00 ± 0.00 0.00 ± 0.00ad 0.00 ± 0.00a 0.00 ± 0.00ab 0.00 ± 0.00e 0.90 ± 0.90e 1.85 ± 1.17e 42.00 ± 0.00
Distilled water 1 ml 6.94 ± 0.26 7.97 ± 0.12 8.67 ± 0.10 8.54 ± 0.07 8.46 ± 0.17 8.70 ± 0.06 8.14 ± 0.27 8.45 ± 0.21 34.33 ± 6.15
Values are mean ± SEM; n = 6; D = day; D0 = the day treatment commenced; SEM = standard error of mean; MeOH =Methanol; ext = extract; DA = Diminazene
aceturate; All superscripts indicate significance at p < 0.05 (a = compared to negative control; b = compared to 3.5 mg/kg DA; c = compared to 28 mg/kg DA;
d = compared to 400 mg/kg; e = compared to all groups).
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group was recorded in all animals after day 6.16 ± 1.42
of treatment. Comparison between the groups treated
with the two types of extracts indicated that the DCM
extract appeared to be superior to the hydromethanolic
extract in reducing the parasite burden. The results
showed that mice treated with 400 mg/kg of DCM extract
had continually reduced parasitaemia level from day 2 of
treatment to day 8 which was further kept on average at
lowest level up to the end of the monitoring period. How-
ever, parasitaemia reduction at higher doses, 400 and
200 mg/kg, of DCM extract and 400 mg/kg hydrometha-
nolic extract were not significantly different.Effect of crude extracts on body weight
Treatment with the crude extracts prevented loss of
weight associated with parasitaemia particularly at 200
and 400 mg/kg dose levels of DCM extract and with
400 mg/kg of hydromethanolic extract compared to the
negative controls. There were no detectable differences
in preventing weight loss associated with parasitaemia
between the extracts as well as between the extracts and
standard (3.5 mg/kg) at these dose levels throughout the
monitoring period (Figure 1a and b). Considerable body
weight improvement was seen by 28 mg/kg DA (12.9%)
followed by 400 mg/kg DCM extract (11.42%) relative to
the pre-treatment value.Effect of crude extracts on packed cell volume
As shown in Figure 2, administration of the plant extracts
to the infected group produced a substantial difference in
PCV when compared with the infected-untreated group.
The prevention of PCV reduction observed at 200 mg/kg
and 400 mg/kg DCM extracts over the infected-untreated
group was comparable. These values were also comparable
between these dose levels and to that caused by the stand-
ard at 28 mg/kg with no statistically significant difference.Effect of crude extracts on differential white blood cell
count
The results in Figure 3a and b indicate that differential
white blood cell (WBC) count revealed that% lymphocyte
counts were significantly higher (p < 0.05) in the groups
that received lowest dose (100 mg/kg) of both extracts,
3.5 mg/kg DA and in the infected-untreated group com-
pared to uninfected-untreated group; whereas marked
decrease (p < 0.05) in neutrophil count was noticed in
these groups.
The lymphocyte and neutrophil levels in the remaining
experimental groups were comparable to that in the
uninfected-untreated group. Comparison with the nega-
tive control, neutrophil levels in all treated groups
except 100 mg/kg hydromethanolic extract, showed no-
ticeable increase (p < 0.05) while lymphocyte levels showed
marked decrease (p < 0.05) except in those groups that
received lowest dose (100 mg/kg) of both extracts and
3.5 mg/kg DA in which the values were similar.
Effect of crude extracts on mean survival time
Analysis of the mean survival time (days) revealed that
only all the mice treated with DA (28 mg/kg) survived
throughout the period of the study (42.00 ± 0.00) com-
pared to groups that received the extracts, standard dose
of DA (3.5 mg/kg) and the infected-untreated control.
Among the extract treated animals, the group treated
with DCM extract at 400 mg/kg had the highest mean
survival time of 40.67 ± 1.00 days (Tables 1 and 2).
Discussion
The objective of the present study was to evaluate the
in vivo antitrypanosomal activity of crude methanolic and
dichloromethane extracts of aerial parts of A. abyssinica
against field isolate of T. congolense in mice models of in-
fection. The in vivo mice study revealed that the extracts
did not completely eliminate the trypanosomes from the






























































Figure 1 Effect of extract of Artemisia abyssinica on body weight of mice. (a) hydromethanolic crude extract (b) dichloromethane crude
extract. Values are mean ± SEM; n = 6; D = day; D0 = the day treatment commenced; a = p < 0.05 compared to negative control; b = p < 0.05
compared to 28 mg/kg DA.
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http://www.biomedcentral.com/1472-6882/14/117level of parasitaemia. Though parasitaemia was not com-
pletely eliminated, taken as a whole, the DCM extract had
the highest antitrypanosomal activity compared to the
hydromethanolic extract and the untreated control. Sev-
eral other workers also made similar observation on the




























Figure 2 Percentage packed cell volume change of T. congolense infect
extracts of aerial parts of A. abyssinica. Values are mean ± SEM; n = 6; PCV
extract; I = 100 mg/kg; II = 200 mg/kg; III = 400 mg/kg; C = 3.5 mg/kg DA;by lipophilic extracts (DCM, chloroform, petroleum
ether) of different plants both in vivo and in vitro (10,
15,19). The finding is in agreement with our former re-
port which showed that DCM extract had better
in vitro antitrypanosomal activity than hydromethanolic








ed mice treated with hydromethanolic and dichloromethane crude
= packed cell volume; A = Hydromethanolic extract; B = Dichloromethane
D = 28 mg/kg DA; E = Negative control; F = uninfected-untreated.
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Figure 3 Effect of extract of Artemisia abyssinica on differential white blood cell count of mice. (a) hydromethanolic crude extract
(b) dichloromethane crude extract. Values are mean ± SEM; n = 6; UU = uninfected-untreated; WBC = white blood cell; a = p < 0.05 compared
to negative control; b = p < 0.05 compared to uninfected-untreated.
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sitaemia but only at its optimum dose of 400 mg/kg
body weight. The high parasite load attained before
commencement of treatment, enzymatic inactivation of
active compounds and impaired absorption from the
site of administration could mask efficacy of crude ex-
tracts to completely clear the parasites in the blood
[21-23]. The fact that the plant showed differential ac-
tivity between extracts is confirmation of earlier asser-
tions [24] that any statement on a plant’s trypanocidal
activity should be taken within the context of the plant
part and the solvent extract tested. This is because dif-
ference in solvent of extraction may reveal different
phytochemicals in the same plant. A similar finding to
earlier reports [15,19,24] in the difference in compos-
ition of secondary metabolites was observed with thetwo solvents of extraction in this investigation which
could in part contribute to the activity difference.
Although diminazene aceturate was able to temporar-
ily clear trypanosomes from circulation of infected mice,
relapse occurred in all experimental mice approximately
on days 6 and 16 of treatment respectively at 3.5 and
28 mg/kg dose levels. This observation was not surpris-
ing as trypanocidal drug resistance has been wide spread
in several African countries including Ethiopia [25-28].
The present study did not involve detailed characteri-
zation and isolation of different compounds that could
be responsible for the observed activity. However, phyto-
chemical screening revealed the presence of tannins, flavo-
noids, alkaloids, cardiac glycosides and polyphenols in the
hydromethanolic extract, and terpenoids, polyphenols and
phytosteroids in the DCM extract [14].
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study might be attributed to the presence of one or more
of these constituents which, in contrast to synthetic phar-
maceuticals based upon single chemicals, may exert their
effects through the additive or synergistic action of several
chemical compounds acting at a single or multiple target
sites associated with a physiological process [29].
Several possible mechanisms working separately or in
concert may account for the observed effect [30]. Accu-
mulated evidences suggest that many natural products
exhibit their antitrypanosomal activity by virtue of their
interference with the redox balance of the parasites acting
either on the respiratory chain or on the cellular defenses
against oxidative stress [24]. This is because natural
products possess structures capable of generating radi-
cals that may cause peroxidative damage to trypa-
nothione reductase that is very sensitive to alterations
in redox balance. Published reports also indicate that
several natural products such as alkaloids, polyphenols,
terpenoids and saponins that primarily interact with im-
portant molecular targets such as DNA, microtubules,
biomembranes, receptors and may induce cytotoxicity
and death in trypanosomes. Several active alkaloids are
known to intercalate DNA, and in consequence inhibit
DNA and RNA polymerase, topoisomerases, ribosomal
protein biosynthesis, or bind to tubulin/microtubules,
thus acting as spindle poisons to disturb membrane integ-
rity in trypanosomes [31].
Trypanosome generated reactive oxygen species can
also attack red blood cells’ membranes, induce oxidation
and subsequently hemolysis. Thus, scavenging the tryp-
anosome associated free radicals by phytochemicals such
as flavonoids and other polyphenolic antioxidants may
ameliorate anemia induced by trypanosome infection [32].
The plant extracts may strengthen the host defense that
was already activated because of the presence of trypano-
somes in circulation with established infection [33].
The mechanism by which these extracts exhibited their
antitrypanosomal activity can only be speculated since the
active ingredient(s) were not isolated. Several investiga-
tions tend to suggest that it is often difficult to speculate
and decipher the exact mode of action by which plant ex-
tracts exhibit their trypanocidal action. Indeed, the possible
mechanisms by which plant extracts and phytochemicals
therein carry out this role remain a subject of great specu-
lations and debate in the scientific community [34]. Thus,
for the DCM extract in our study, the antitrypanosomal
effect produced would most likely be ascribed to either of
the terpenoids, polyphenols or phytosteroids detected in
the extract. However, rare findings have suggested as to
how any of these phytochemicals produce their antitrypa-
nosomal activity. The result of Nibret et al. [10] has clearly
indicated that out of the 40 plant extracts tested, the
DCM extract from stem bark of Warburgia salutaris(claimed to be used against many pathologies in many
parts of Africa) was found to exhibit the most potent
trypanocidal activity. The trypanocidal activity was sug-
gested to be due to the drimane sesquiterpenoids (war-
burganal and polygodial). Concerning the mechanism,
it was proposed that the two sesquiterpene aldehydes,
warburganal and polygodial, formed covalent bonds
with amino groups of proteins and affect a vast number
of cellular activities.
The positive effect of the extracts against trypanosome
infection can further be deduced from the weight status
of the animals and the body weight improvement was
consistent with the observation made on parasitaemia.
This observation indicates that the animals with better
physical state could feed more than those in the other
groups and resist weight loss that is usually associated
with trypanosomiasis.
The observed antitrypanosomal effect of the extracts
in this study was accompanied by corresponding im-
provement and prevention of further drop in PCV sug-
gesting that they have potentials to ameliorate anaemia.
This could possibly be by reducing the proliferating para-
site load, neutralizing the toxic metabolites produced by
trypanosomes or scavenging the trypanosome associated
free radicals [15,21,35]. This was particularly noticed in
the second week of treatment, in groups with significantly
reduced parasitaemia, where the final PCV values were al-
most similar to the pre-treatment values. The infected
mice treated with the standard drug (diminazine acetu-
rate) at 28 mg/kg showed nearly stable PCV up to day 14
of treatment although relapse occurred in all animals after
16 days post treatment. In contrast, the recommended
standard dose for cattle and mice (3.5 mg/kg) was unable
to prevent PCV reduction suggesting its failure to elimin-
ate parasitaemia. Similar observations have been reported
in previous studies [26,36,37].
Lymphocytes are the main effector cells of the immune
system [38]. Results of the differential white blood cell
count revealed that higher differential lymphocyte
counts were generally recorded in those groups in
which parasitaemia was not relatively kept in check
and in the infected-untreated. Leucocytosis which may
be due to lymphocytosis have been implicated in tryp-
anosomiasis and these conditions are usually as a re-
sult of wax and wear syndrome on the animal immune
system caused by the ever changing variable surface
glycoprotein of the infecting trypanosomes [39] that
demands the immune system to continuously produce
antibodies and hence keep the level of lymphocytes
high. However, administration of the extracts that have
significantly lowered parasitaemia seemed to prevent
lymphocytosis suggesting that this phenomenon is a
result of parasite load. Hence, the relatively reduced
percentage of lymphocytes post extract treatment
Feyera et al. BMC Complementary and Alternative Medicine 2014, 14:117 Page 8 of 9
http://www.biomedcentral.com/1472-6882/14/117suggests that the plant extracts by suppressing parasit-
aemia contributed to the attenuation of the immuno-
logical reaction.
The lower differential counts of neutrophils observed
in the infected negative control and groups in which
parasitaemia was persistently higher may be attributed
to the immunosuppressive actions of trypanosome infec-
tion [39-41]. Several mechanisms such as granulocyte
hypoplasia and splenic sequestration have been proposed
for neutropenia in African trypanosomiasis [42]. It has
been suggested that granulocyte progenitor cells may be
coated with trypanosome antigen-antibody as occurs
with RBC leading to phagocytosis [43]. In this study, we
suggest that treatment with crude extracts of aerial parts
A. abyssinica has reduced parasite load consequently lead-
ing to a decrease in coating of the progenitor cells which
prevented or reduced the development of neutropenia.
Neither the extracts nor the standard drug cured the
infection although parasitaemia was kept in check. Earlier
reports indicated that in T. congolense infections probably
the long lasting chronic wasting situation and a complex
process of gradual impairment of organs and tissues of
the host lead to the eventual generalized collapse. A suf-
ficiently balanced situation in the host-parasite relation-
ship might allow the establishment of a chronic infection
that could lead to survival of infected animals for several
months [44]. The mice in all groups that showed high
levels of parasitaemia survived for at least 34 days showing
that they resisted the parasites for appreciable period of
time.
Conclusion
In vivo assay of the present investigation has provided
evidence that extracts of aerial parts of A. abyssinica
have reduced parasite burden and ameliorated anaemia,
prevented body weight loss, increased neutrophil levels
and decreased lymphocyte levels as a consequence of the
parasites being kept in check and DCM extract showed a
superior antitrypanosomal activity than hydromethanolic ex-
tract. This study established that aerial parts of A. abyssinica
have antitrypanosomal potential and can be considered a
potential source of new drugs for the treatment of tropical
diseases caused by trypanosomes.
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